Avidity Partners Management

Latest statistics and disclosures from Avidity Partners Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Avidity Partners Management

Avidity Partners Management holds 92 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Call Option 6.2 $297M NEW 3.3M 89.88
Astrazeneca Sponsored Adr (AZN) 5.1 $246M +29% 3.7M 66.34
Abbvie (ABBV) 4.9 $238M -26% 1.5M 162.11
Arvinas Ord (ARVN) 4.1 $196M +15% 2.9M 67.30
Anthem (ELV) 4.1 $196M +24% 399k 491.22
Merck & Co (MRK) 4.0 $195M NEW 2.4M 82.05
Avantor (AVTR) 4.0 $192M +18% 5.7M 33.82
Baxter International (BAX) 3.1 $149M +8% 1.9M 77.54
Zentalis Pharmaceuticals (ZNTL) 3.1 $147M +17% 3.2M 46.14
Biohaven Pharmaceutical Holding (BHVN) 3.0 $146M +7% 1.2M 118.57
Vertex Pharmaceuticals Incorporated (VRTX) 3.0 $142M +94% 546k 260.97
UnitedHealth (UNH) 2.8 $132M +110% 260k 509.97
United Therapeutics Corporation (UTHR) 2.7 $129M +34% 719k 179.41
Horizon Therapeutics Pub L SHS (HZNP) 2.5 $119M +11% 1.1M 105.21
Mirati Therapeutics (MRTX) 2.4 $115M +72% 1.4M 82.22
Iveric Bio (ISEE) 2.3 $109M -6% 6.5M 16.83
Neurocrine Biosciences (NBIX) 2.3 $109M -7% 1.2M 93.75
Iovance Biotherapeutics (IOVA) 2.1 $101M +59% 6.0M 16.65
Intuitive Surgical Com New (ISRG) 2.0 $98M NEW 325k 301.68
Catalent (CTLT) 1.8 $87M +12% 782k 110.90
Humana (HUM) 1.8 $87M NEW 199k 435.17
Syndax Pharmaceuticals (SNDX) 1.7 $84M 4.8M 17.38
Biogen Idec (BIIB) 1.6 $77M NEW 365k 210.60
Ultragenyx Pharmaceutical (RARE) 1.3 $63M +24% 869k 72.62
Johnson & Johnson (JNJ) 1.3 $63M NEW 354k 177.23
Adicet Bio (ACET) 1.3 $62M +2% 3.1M 19.97
Kezar Life Sciences (KZR) 1.2 $59M +8% 3.5M 16.62
McKesson Corporation (MCK) 1.2 $58M NEW 190k 306.13
Argenx Se Sponsored Adr (ARGX) 1.2 $56M NEW 176k 315.31
Boston Scientific Corporation (BSX) 1.1 $53M NEW 1.2M 44.29
Natera (NTRA) 1.1 $53M +38% 1.3M 40.68
Edwards Lifesciences (EW) 1.1 $52M NEW 440k 117.72
Arrowhead Pharmaceuticals (ARWR) 0.9 $44M +9% 955k 45.99
Immunocore Hldgs Ads (IMCR) 0.8 $41M +10% 1.4M 29.90
Legend Biotech Corp Sponsored Ads (LEGN) 0.8 $40M +53% 1.1M 36.34
Spdr Ser Tr S&p Biotech (XBI) 0.8 $40M NEW 440k 89.88
Bausch Health Companies (BHC) 0.8 $39M NEW 1.7M 22.85
Avidity Biosciences Ord (RNA) 0.8 $38M +12% 2.0M 18.47
Insmed Com Par $.01 (INSM) 0.7 $32M -6% 1.4M 23.50
Alphatec Hldgs Com New (ATEC) 0.7 $32M 2.7M 11.50
Ideaya Biosciences (IDYA) 0.6 $30M +5% 2.7M 11.19
Chemocentryx (CCXI) 0.6 $30M +82% 1.2M 25.07
Axsome Therapeutics (AXSM) 0.6 $29M -8% 711k 41.39
Arcus Biosciences Incorporated (RCUS) 0.6 $29M NEW 912k 31.56
Intellia Therapeutics (NTLA) 0.6 $28M NEW 390k 72.67
Phathom Pharmaceuticals (PHAT) 0.6 $27M +2% 1.9M 13.61
Caribou Biosciences (CRBU) 0.5 $26M +5% 2.8M 9.18
Nuvation Bio Com Cl A (NUVB) 0.5 $26M -34% 4.9M 5.26
Bellus Health Com New (BLU) 0.5 $25M -2% 3.7M 6.88
Seaspine Holdings (SPNE) 0.5 $24M 2.0M 12.16
Penumbra (PEN) 0.5 $23M NEW 104k 222.13
Si-bone (SIBN) 0.5 $23M 1.0M 22.60
Vir Biotechnology (VIR) 0.4 $20M +11% 780k 25.72
Miragen Therapeutics (VRDN) 0.4 $19M -18% 1.0M 18.49
Blueprint Medicines (BPMC) 0.4 $19M -70% 291k 63.88
Altimmune Com New (ALT) 0.4 $17M +3% 2.9M 6.09
Essa Pharma Com New (EPIX) 0.3 $15M 2.5M 6.18
Seagen (SGEN) 0.3 $14M -85% 100k 144.05
Galapagos Nv Spon Adr (GLPG) 0.3 $13M NEW 215k 62.02
Century Therapeutics (IPSC) 0.2 $11M 865k 12.59
Alpine Immune Sciences (ALPN) 0.2 $11M -10% 1.2M 8.97
Apellis Pharmaceuticals (APLS) 0.2 $11M NEW 210k 50.81
An2 Therapeutics (ANTX) 0.2 $10M NEW 688k 15.07
Erasca (ERAS) 0.2 $8.6M NEW 995k 8.60
Sentinelone Cl A (S) 0.2 $7.9M 205k 38.74
Cyteir Therapeutics (CYT) 0.1 $7.0M 1.9M 3.77
Phasebio Pharmaceuticals (PHAS) 0.1 $5.8M 4.4M 1.32
Caremax Com Cl A (CMAX) 0.1 $5.6M -8% 755k 7.47
Tango Therapeutics (TNGX) 0.1 $5.5M +2% 721k 7.58
Hyperfine Com Cl A (HYPR) 0.1 $5.3M 1.5M 3.54
Medicus Sciences Acquisition Cl A Shs (MSAC) 0.1 $5.1M 520k 9.78
Bcls Acquisition Corp Com Cl A (BLSA) 0.1 $4.9M 500k 9.87
Dynamics Special Purpose Cor Class A Com 0.1 $4.9M 500k 9.87
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.1 $4.9M 500k 9.80
Panacea Acquisition Corp Ii Cl A Shs (PANA) 0.1 $4.9M 500k 9.75
Helix Acquisition Corp Com Cl A 0.1 $4.4M 400k 11.10
Field Trip Health Ord 0.1 $4.0M -7% 3.0M 1.34
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.1 $4.0M 400k 9.91
Graphite Bio (GRPH) 0.1 $3.6M 710k 5.10
Oncosec Medical Incorporated (ONCS) 0.1 $3.4M 2.9M 1.15
Otonomy (OTIC) 0.1 $3.2M NEW 1.3M 2.40
Sema4 Holdings Corp Com Cl A (SMFR) 0.1 $2.9M 950k 3.07
Compass Therapeutics (CMPX) 0.1 $2.7M 2.0M 1.37
Gritstone Oncology Ord (GRTS) 0.0 $2.3M -87% 560k 4.12
Science 37 Holdings (SNCE) 0.0 $2.3M +9% 430k 5.35
Scynexis Com New (SCYX) 0.0 $2.1M -75% 544k 3.91
Social Cap Suvretta Hld Crpi Class A Ord Shs 0.0 $2.0M 200k 9.90
Social Cap Suvretta Hlds Crp Class A Ord Shs 0.0 $2.0M 200k 9.89
Social Cap Suvretta Hlds Crp Class A Ord Shs (DNAB) 0.0 $2.0M 200k 9.75
Social Cap Suvretta Hlds Cp Class A Ord Shs (DNAD) 0.0 $1.9M 200k 9.74
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) 0.0 $76k 100k 0.76
Medicus Sciences Acquisition *w Exp 02/12/202 (MSACW) 0.0 $25k 58k 0.43

Past Filings by Avidity Partners Management

SEC 13F filings are viewable for Avidity Partners Management going back to 2019